Ex-Visium hedge fund
manager cheated investors, U.S. jury hears
Send a link to a friend
[January 12, 2017]
By Nate Raymond
NEW
YORK (Reuters) - An ex-portfolio manager at Visium Asset Management LP
corruptly sought to boost the value of one of its hedge fund's holdings,
defrauding investors while enabling the investment firm to earn millions
of dollars, a U.S. prosecutor told jurors on Wednesday.
Stefan Lumiere, the former brother-in-law of Visium founder Jacob
Gottlieb, violated the trust of investors through "fraud and lies,"
Assistant U.S. Attorney Damian Williams told jurors at the start of a
trial in federal court in Manhattan.
Lumiere and others rigged the process of valuing the bond fund's
distressed-debt holdings by, among other things, obtaining sham quotes
from brokers, who gave them the inflated values they wanted, Williams
said in his opening statement.
"Ladies and gentleman, it is easy to look like a winner when you can
make up the score," Williams said.
But defense lawyer Eric Creizman said Lumiere, 46, was innocent. He
urged jurors to be skeptical of two cooperating witnesses formerly with
Visium, and contended Lumiere acted in "good faith" in obtaining values
for the fund's securities.
"This is not picking a price out of the air," he said. "It was based on
a number of things."
The trial follows a probe of Visium that prompted the $8 billion firm's
wind-down and charges against three others, including Sanjay Valvani, a
portfolio manager who committed suicide in June after being accused of
insider trading.
Lumiere, who faces securities fraud and other charges, began working at
Visium in 2007 and served as portfolio manager for Visium Credit
Opportunities Fund from May 2009 to April 2013.
[to top of second column] |
Stefan Lumiere (C) departs Federal Court after a hearing following
his arrest in New York, U.S. on June 15, 2016. REUTERS/Lucas
Jackson/File Photo
From 2011 to 2013, prosecutors said, Lumiere and others, including
portfolio manager Christopher Plaford, schemed to defraud investors by
mismarking the value of securities held by the fund, which invested in
debt issued by healthcare companies.
Prosecutors said the practices caused the fund's net asset value to be
overstated by tens of millions of dollars each month and deceived
investors into believing the bonds were relatively liquid, when they
were not.
At trial, prosecutors plan to call as cooperating witnesses Plaford, who
pleaded guilty in June, and Jason Thorell, a former Visium trader who
Williams said turned whistleblower by taking the matter to the U.S.
Securities and Exchange Commission.
Thorell, who is expected to testify on Thursday, stands to potentially
earn a monetary reward for cooperating, a fact Lumiere's attorneys say
indicates he is seeking a recovery from the SEC's whistleblower program.
The case is U.S. v. Lumiere, U.S. District Court, Southern District of
New York, No. 16-cr-00483.
(Reporting by Nate Raymond in New York; Editing by Leslie Adler)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|